ANP (Atrial Natriuretic Peptide) Dosage Guide

Complete guide to ANP (Atrial Natriuretic Peptide) dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Clinical use: Carperitide (recombinant ANP) used in Japan for acute heart failure at 0.1mcg/kg/min IV infusion.

Administration Method

Intravenous infusion only for clinical applications. Short half-life (~2 minutes) requires continuous administration.

Side Effects to Monitor

Hypotension (dose-limiting), headache, nausea, and potential arrhythmias at high doses.

Safety Considerations & Risks

Significant hypotension risk. Requires careful monitoring. Not widely approved outside Japan.